Has a generic version of Zithromax been approved?
Yes. The following products are equivalent to Zithromax:
(Manufacturer: PFIZER)
azithromycin for suspension;oral
Manufacturer: AMNEAL PHARMS LLC (AMRX)
Approval date: July 19, 2018
Strength(s): EQ 100MG BASE/5ML [AB], EQ 200MG BASE/5ML [AB]
This says Amneal can manufacture this drug.
(I do not find it listed on there site at present but it is listed at AvKare.)
https://www.drugs.com/availability/generic-zithromax.html
AvKare on its products page lists it below PIC.
IMHO it should give easier access for DOD, VA and U.S. federal
agency sectors through (AMRX) Avkare distribution channels.
(AMRX)
Recent AMRX News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/31/2024 10:51:29 PM
- Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets • Business Wire • 10/21/2024 12:00:00 PM
- Amneal to Report Third Quarter 2024 Results on November 8, 2024 • Business Wire • 10/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 11:10:25 AM
- Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases • Business Wire • 10/01/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:17:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:27:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 10:14:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:10:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 07:13:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:38:53 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/13/2024 08:15:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:46:14 PM
- Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203 • GlobeNewswire Inc. • 01/25/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 12:03:53 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/05/2024 09:09:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:36:04 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:30:21 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM